Indonesia

EPSI began operating in the country upon establishment of its Jakarta office in 2006. The population of about 250 million makes Indonesia the fourth most populous country in the world. It is also ethnically diverse. The country features excellent compliance to Good Clinical Practice standards in all clinical trials. A large pool of potential research participants and low cost of research provide opportunities to accelerate recruitment and trial times, making Indonesia a very attractive location for clinical trials.

Fast Facts

Health Expenditure per Capita
(2014, US$)

$299

Source: World Health Organization Global Health Expenditure Database

Life Expectancy at Birth
(2016 est.)

male

70

years

female

75

years

Source: The World Fact Book;
Central Intelligence Agency

Burden of Disease DALYs Causes % of Total DALYs
(2015, all ages/both sexes)

Cerebrovascular disease (8.58%)

Ischemic heart disease (7.42%)

Diabetes mellitus (5.34%)

Source: Global Burden of Disease Study 2015;
Institute for Health Metrics and Evaluation

NDA Approval Time

8

months

–

12

months